Results for
"[search-keyword]"
Sponsor content
35 result(s) found, displaying 1 to 10
- AusPAR: Spikevax XBB.1.5Australian Public Assessment Report (AusPAR)AusPAR for Spikevax XBB.1.5 (andusomeran) for the prevention of COVID-19 caused by SARS-CoV-2 in individuals 12 years of age and older.
- SPIKEVAX XBB.1.5 (andusomeran) COVID-19 VACCINE 0.1 mg/mL suspension for injection vial - single-dose (418910)ARTGAustralian Register of Therapeutic Goods (ARTG) information for SPIKEVAX XBB.1.5 (andusomeran) COVID-19 VACCINE 0.1 mg/mL suspension for injection vial - single-dose.
- SPIKEVAX XBB.1.5 (andusomeran) COVID-19 VACCINE 0.1 mg/mL suspension for injection pre-filled syringe (418911)ARTGAustralian Register of Therapeutic Goods (ARTG) information for SPIKEVAX XBB.1.5 (andusomeran) COVID-19 VACCINE 0.1 mg/mL suspension for injection pre-filled syringe.
- AusPAR: Spikevax Bivalent Original/Omicron BA.4 - 5Australian Public Assessment Report (AusPAR)AusPAR for Spikevax Bivalent Original/Omicron BA.4 - 5 (Elasomeran/davesomeran) for the prevention of coronavirus disease 2019 caused by SARS-CoV-2.
- TBC Moderna Australia Pty LtdJul-2023Prescription medicine evaluationActive ingredient: respiratory syncytial virus F protein mRNA (nucleoside modified).
- SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.4-5 (elasomeran/davesomeran) COVID-19 VACCINE 0.1 mg/mL suspension for injection vial-single dose (406730)ARTGAustralian Register of Therapeutic Goods (ARTG) information for SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.4-5 (elasomeran/davesomeran) COVID-19 VACCINE 0.1 mg/mL suspension for injection vial-single dose.
- AusPAR: SpikevaxAustralian Public Assessment Report (AusPAR)New AusPAR for Spikevax (elasomeran) for the prevention of COVID-19 caused by SARS-CoV-2.
- Notice for mRNA-1345 (for Respiratory Syncytial Virus (RSV) pre-fusion F protein (Moderna Australia Pty Ltd)Designation or determinationPriority review
- AusPAR: Spikevax bivalent Original/Omicron BA.4-5Australian Public Assessment Report (AusPAR)AusPAR for SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.4-5 (elasomeran/davesomeran) as booster dose for active immunisation to prevent COVID-19
- Spikevax bivalent Original/Omicron BA.4-5Prescription medicine decision summaryapproved to prevent coronavirus disease 2019 (COVID-19)